Major Leadership Shakes in Global MedTech Firms Throughout 2024

▲Source of the article: Eshare Medical Device Hub

▲Please indicate the above source at the beginning of the article when reprinting.

In the blink of an eye, 2024 is almost over. On the eve of 2025, let's take a look at what's coming.Changes in the company's senior management

As a giant in the medical device industry, Medtronic's significant personnel changes in 2024 have been astonishing.

February 2024,Medtronic Announces Departure of EVP and President of Medical Surgical Portfolio, Bob WhiteBob White served at Medtronic for 14 years, leading the company's integration with Covidien. Following White's departure, Mike Marinaro has taken over the leadership of the Medical Surgical business.

In addition,President of the Respiratory Interventions DivisionAriel Mactavish andPresident of the Gastrointestinal DepartmentGio Di Napoli also announced his resignation successively, and Raj Thomas took over the management of the gastrointestinal department.

June 2024,Executive Vice President, Global RegionsRob ten Hoedt Announces Retirement, Followed by,Chief Financial OfficerKaren Parkhill announced her resignation and joined HP.

Subsequently, in August 2024,Chief Medical Officer of Acute Care and Monitoring DivisionSam Ajizian Announces Departure.

September,Chief Medical Officer of the Structural Heart DivisionJeffrey Popma also announced his retirement, to be succeeded by Dr. Kendra Grubb.

In October 2024, Olympus announced the removal of CEO Stefan Kaufmann from his position,The reason is that he is suspected of purchasing illegal drugs.

Kaufmann has served as CEO since April 2023, following over 20 years at Olympus. After Kaufmann's departure, Yasuo Takeuchi returned to the role of CEO to continue leading the company's development.

Kaufmann admitted to the wrongdoing after resigning, and Olympus is continuing its search for a new CEO.

LivaNova Appoints New CEO:

LivaNova Appoints Vladimir Makatsaria as CEO in 2024, Replacing Bill Kozy

Makatsaria worked at Johnson & Johnson for nearly 30 years, ultimately leading the global operations of the Ethicon surgical business.

After joining LivaNova, Makatsaria will focus on advancing the company's businesses in the cardiopulmonary and neuromodulation fields, especially against the backdrop of the company planning to scale back its advanced circulatory support business.

CVRx Appoints New CEO:

CVRx Appoints Kevin Hykes as CEO in 2024, Replacing Nadim Yared Who is Set to Retire.

Hykes previously served as the CEO of Augmedics and has been a member of the CVRx Board of Directors since 2022.

Integra LifeSciences' New CEO:

Integra LifeSciences Welcomes New Leadership in 2024

Jan De Witte announced retirement in 2024, and Mojdeh Poul succeeded as the new President and CEO.

Mojdeh Poul has extensive experience in the medical technology industry, and his joining will drive Integra LifeSciences to achieve technological innovation in the fields of neurosurgery and orthopedics, and expand its influence in the global market.

ZimVie Spine Business Leadership Changes:

In 2024, ZimVie sold its spine business to HIG Capital, and the new company was named Highridge Medical.

Rebecca Whitney Becomes CEO of New Company Highridge Medical After Spine Business Sale

Highridge Medical also includes ZimVie's EBI bone healing business, with Glen Kashuba continuing to lead EBI.

This change marks a new direction for ZimVie after its restructuring and lays the foundation for Highridge Medical's innovation in the field of spinal treatment.

CMR Surgical Leadership Adjustment:

Supratim Bose, CEO of CMR Surgical, resigned in October 2024 for personal reasons, and Massimiliano Colella took over as interim CEO.

BOse will continue to serve as vice chairman of the board after resigning.

CMR Surgical's Versius platform received FDA De Novo clearance the same year, providing significant support for the company’s future surgical robotic technology.

Scan the QR code in the image below to purchase.

‍